McKesson to acquire Precision Medicine Group
Move will enhance McKesson's clinical research and commercialization services.
McKesson Corp.
InspiroGene by McKesson expands U.S. patient access to Kite’s CAR T-Cell Therapies through new distribution partnership
The collaboration will focus on ensuring that patients who are eligible for CAR T-cell therapy can access Kite’s treatments when and where they need them.
McKesson inks agreement with Apollo Funds for strategic minority interest in medical-surgical solutions
This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public offering.
McKesson Corp. announces planned CFO transition
Britt Vitalone announces retirement, Kenny Cheung named as successor.
McKesson Corp. completes divestiture of Norwegian operations
The transaction represents the final step in McKesson’s commitment to fully exit its European operations.
USAntibiotics working with Walmart and McKesson to support U.S. manufacturing of amoxicillin
Project affirms commitment to supporting the domestic pharmaceutical industry and strengthens pharmacy supply chain.
McKesson continues to roll with shifts in traditional retail pharmacy
Bresnahan pointed out that community pharmacy needs to diversify,“ to respond to the market shifts, [particularly] as traditional prescription volume starts to shift away from traditional retail pharmacy.”
Registration opens for Annual McKesson ideaShare Conference
McKesson invites independent pharmacy owners and their teams to register and attend premier education and networking event.
McKesson Corp. completes PRISM Vision Holdings deal
Announces fourth quarter and full year fiscal 2025 earnings release date.